Skip to content

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).

Randomized controlled trial · J Alzheimers Dis · 2022. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 35275529

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Moderate Alzheimer's Disease (DRAMA).

Shim Y, Han HJ, Park KW et al.
J Alzheimers Dis · 2022

PubMed ID
35275529
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.